These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22232996)

  • 21. Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography.
    Kakihara D; Nishie A; Harada N; Shirabe K; Tajima T; Asayama Y; Ishigami K; Nakayama T; Takayama Y; Okamoto D; Fujita N; Kishimoto J; Honda H
    J Magn Reson Imaging; 2014 Nov; 40(5):1112-20. PubMed ID: 24259437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
    Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretransplantation evaluation of the cirrhotic liver with explantation correlation: accuracy of CT arterioportography and digital subtraction hepatic angiography in revealing hepatocellular carcinoma.
    Steingruber IE; Mallouhi A; Czermak BV; Waldenberger P; Gassner E; Offner F; Chemelli A; Koenigsrainer A; Vogel W; Jaschke WR
    AJR Am J Roentgenol; 2003 Jul; 181(1):99-108. PubMed ID: 12818838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant.
    Poullos PD; Tseng JJ; Melcher ML; Concepcion W; Loening AM; Rosenberg J; Willmann JK
    AJR Am J Roentgenol; 2018 Apr; 210(4):766-774. PubMed ID: 29470153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list.
    Toso C; Dupuis-Lozeron E; Majno P; Berney T; Kneteman NM; Perneger T; Morel P; Mentha G; Combescure C
    Hepatology; 2012 Jul; 56(1):149-56. PubMed ID: 22271250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of the single liver nodule in a cirrhotic patient: a decision analysis model.
    El-Serag HB; Mallat DB; Rabeneck L
    J Clin Gastroenterol; 2005 Feb; 39(2):152-9. PubMed ID: 15681913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Milan criteria versus San Francisco criteria in hepatocellular carcinoma: our center's experience.
    Sánchez Antolín G; García Pajares F; Pérez E; Villacastín E; Ruiz Rebollo L; Sánchez DP; Cítores MA; Velicia Llames R
    Transplant Proc; 2009 Apr; 41(3):1012-3. PubMed ID: 19376413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the waiting list by using 75-year-old donors for recipients with hepatocellular carcinoma.
    Cascales Campos PA; Romero PR; Gonzalez R; Zambudio AR; Martinez Frutos IM; de la Peña J; Bueno FS; Robles Campos R; Miras M; Pons Miñano JA; Sanmartin Monzo A; Domingo J; Bixquert Montagud V; Parrilla Paricio P
    Transplant Proc; 2010 Mar; 42(2):627-30. PubMed ID: 20304209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT.
    Marin D; Catalano C; De Filippis G; Di Martino M; Guerrisi A; Rossi M; Passariello R
    AJR Am J Roentgenol; 2009 Jan; 192(1):180-7. PubMed ID: 19098199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
    Cheung TT; Ho CL; Lo CM; Chen S; Chan SC; Chok KS; Fung JY; Yan Chan AC; Sharr W; Yau T; Poon RT; Fan ST
    J Nucl Med; 2013 Feb; 54(2):192-200. PubMed ID: 23321459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT.
    Valls C; Cos M; Figueras J; Andía E; Ramos E; Sánchez A; Serrano T; Torras J
    AJR Am J Roentgenol; 2004 Apr; 182(4):1011-7. PubMed ID: 15039179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT.
    Lee HM; Lu DS; Krasny RM; Busuttil R; Kadell B; Lucas J
    AJR Am J Roentgenol; 1997 Jul; 169(1):125-30. PubMed ID: 9207511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
    Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
    Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ; Kim YK; Lee MH; Lee JH
    Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma.
    Herrero JI; Sangro B; Quiroga J; Pardo F; Herraiz M; Cienfuegos JA; Prieto J
    Liver Transpl; 2001 Jul; 7(7):631-6. PubMed ID: 11460231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
    Chalasani N; Horlander JC; Said A; Hoen H; Kopecky KK; Stockberger SM; Manam R; Kwo PY; Lumeng L
    Am J Gastroenterol; 1999 Oct; 94(10):2988-93. PubMed ID: 10520857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility.
    Kim PN; Choi D; Rhim H; Rha SE; Hong HP; Lee J; Choi JI; Kim JW; Seo JW; Lee EJ; Lim HK
    J Vasc Interv Radiol; 2012 May; 23(5):627-34. PubMed ID: 22387030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass.
    Marrero JA; Hussain HK; Nghiem HV; Umar R; Fontana RJ; Lok AS
    Liver Transpl; 2005 Mar; 11(3):281-9. PubMed ID: 15719410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis.
    Iannaccone R; Laghi A; Catalano C; Rossi P; Mangiapane F; Murakami T; Hori M; Piacentini F; Nofroni I; Passariello R
    Radiology; 2005 Feb; 234(2):460-7. PubMed ID: 15671002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.